This study developed an evidence-based, goal-directed haemodynamic management algorithm to standardize intraoperative haemodynamic therapy. A systematic literature search identified three haemodynamic management goals: stroke volume optimization by fluid therapy; maintenance of a target mean arterial pressure by vasopressor therapy; maintenance of a target cardiac index ≥ 2.5 l/min per m 2 by inotropic therapy. The algorithm was adapted to international standards and consensus was reached through a modified Delphi method at international meetings. Implementation of the algorithm into routine intraoperative management in noncardiac surgery was shown to be feasible. Compared with conventional haemodynamic management, use of the algorithm significantly reduced length of hospital stay, requirement for ventilation and incidence of prolonged hospital stay, thereby resulting in reduced hospital costs.
Introduction
Haemodynamic management by anaesthetists is a cornerstone of perioperative patient care and has a significant impact on postoperative complication rates and length of hospital stay. 1 -4 Despite this, there is wide variability in the haemodynamic targets used to improve patient outcomes, 5 -9 and studies do not commonly define perioperative haemodynamic management. Failure to control this crucial part of patient management can confound successful surgical outcomes. Standardization of intraoperative haemodynamic therapy, using an algorithm for goal-directed haemodynamic management, could allow a A Feldheiser, P Conroy, T Bonomo et al.
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comparison of different monitoring studies and infusion regimens; this would minimize the confounding effect of nonprotocolized haemodynamic management in perioperative care.
The aim of the present study was to create a treatment algorithm by identifying clinically relevant intraoperative haemodynamic indices. The clinical feasibility and impact on postoperative outcome of the algorithm was investigated in different types of noncardiac surgery.
Algorithm development
A goal-directed haemodynamic algorithm was developed through a systematic literature search followed by a critical appraisal of the evidence by a group of experts, the core group of which included the authors of the present paper and anaesthetist members of the Anaesthesia Working Group of the Enhanced Recovery After Surgery (ERAS ® ) Society. The following steps were performed: (i) definition of the search criteria for the key words of interest and identification of relevant literature databases; (ii) systematic literature search of the identified original literature and guidelines, recommendations and expert opinions; (iii) evaluation of publications to identify appropriate haemodynamic management targets; (iv) discussion of the draft algorithm and core statements, and integration of internal evidence including unpublished studies and expert experience.
The key features of the algorithm were approved after two consensus meetings of the ERAS ® Society group in Edinburgh, UK (April 2008) and Berlin, Germany (September 2008). Consensus was reached through a modified Delphi method, with particular emphasis placed on the level of evidence, ethical aspects, clinical relevance, risk : benefit ratios, degree of applicability, and feasibility of applying the algorithm across a broad range of international healthcare delivery systems. The final algorithm is shown in Fig. 1 .
LITERATURE SEARCH STRATEGY
A systematic search of electronic databases was conducted to identify English-or Germanlanguage publications listed between January 1985 and September 2008 in The Cochrane Library, MEDLINE ® via PubMed ® and EMBASE electronic databases. In total, 1464 articles were identified using predefined search words as text words and/or MeSH terms (anaesthesia AND haemodynamic monitoring AND haemodynamic therapy AND surgery). Review of publication titles and abstracts selected 63 articles for further analysis. Articles that did not have the desired themes, duplicated data from the same author, focused mainly on pharmacological models and animal experiments, or that cited data published before 1985 were excluded. Following inclusion of literature known to the expert reviewers, 22 publications were used for the development of the algorithm. All publications were evaluated using the evidence criteria described by the Oxford Centre for Evidence-based Medicine. 10 Review of the literature focused on the identification of protocols or parameters to guide haemodynamic therapy in elective noncardiac surgery.
An update of the literature search was performed in April 2011 for the period between September 2008 and March 2011. A total of 429 articles were identified using the same search strategy as described above. Review of publication titles and abstracts yielded 19 articles for further analysis.
GRADE OF RECOMMENDATION

Recommendations
for haemodynamic management were graded for relevance. 
META-ANALYSES
In order to establish an average weighted effect size for postoperative morbidity, metaanalyses were conducted using the Mantel-Haenszel test with fixed-and random-effects models. Results were summarized using forest plots, and relative risks (RR) and 95% confidence intervals (CI) were calculated. Calculations were performed using the R Project for Statistical Computing, version 2.12.1 (available at: www.r-project.org). A P-value < 0.05 was considered to be statistically significant.
SYSTEMATIC LITERATURE REVIEW
The systematic literature search revealed three goals to guide haemodynamic therapy in noncardiac surgery. Goals determined to be most relevant to patient outcome were: optimization of stroke volume by fluid therapy; maintenance of a target mean arterial pressure by vasopressor treatment; target cardiac index of ≥ 2.5 l/min per m 2 to avoid a low cardiac output state. Recommendations are outlined in Table 1 .
Stroke volume
Randomized controlled trials (RCTs) with the aim of calculating fluid administration by generalized administration protocols through liberal, restrictive or standard regimens were used as the reference to specify the baseline crystalloid infusion rates for the haemodynamic algorithm. These studies are reviewed elsewhere. 1,12 Goaldirected fluid therapy has been shown to improve patient outcomes more consistently 
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ERAS feasibility study in a greater range of RCTs than generalized fluid administration protocols. 1 As such, a goal-directed fluid protocol was chosen as the preferred method to optimize fluid therapy in the present algorithm.
The parameters identified to predict fluid responsiveness and/or to guide fluid and volume therapy were: stroke volume as measured by oesophageal Doppler ultrasonography, pulse contour analysis or pulmonary artery catheter; variability of stroke volume and pulse pressure; central venous pressure (CVP); corrected flow time (FTc); central venous and mixed venous oxygen saturation, as outlined in Table  2 . 5 -8,13 -24 The results of fixed-and randomeffects meta-analyses are shown in Fig. 2 .
Preload optimization guided by stroke volume, as measured by oesophageal Doppler ultrasonography, was almost always associated with a significant reduction in length of hospital stay and postoperative morbidity (Table 2) . 7,8,13 -17 In contrast to these studies, investigations based on the measurement of stroke volume by the Vigileo™ monitor/FloTrac™ sensor (Edwards Lifesciences, Irvine, CA, USA) 6, 18, 19 or by the lithium indicator dilution cardiac output (LiDCO™; Lidco, Cambridge, UK) system 20 did not uniformly improve outcome (Table 2) . There is no evidence that the use of a pulse contour method to guide intraoperative fluid therapy by measuring stroke volume is equivalent to guiding fluid administration by oesophageal Doppler ultrasonography. In high-risk patients, there is some evidence of improved outcome when using a pulmonary artery catheter for perioperative preload optimization. 4, 25, 26 According to published guidelines, however, this method is justified only in high-risk patients undergoing complex cardiac surgery, in severe low cardiac output syndrome or pulmonary hypertension, and for the differentiation between severe right or left ventricular dysfunction. 27 For this reason, the use of a pulmonary artery catheter is not considered appropriate for haemodynamic management algorithms in elective noncardiac surgery. 28 Oesophageal Doppler ultrasonography was chosen as the preferred method of monitoring intraoperative stroke volume due to the broader evidence base in this context.
Measurement of CVP or FTc for haemodynamic monitoring was performed concomitantly in several of the studies that assessed stroke volume measurement by oesophageal Doppler-guided fluid monitoring. 7,8,13 -17 The beneficial effects of fluid challenge guided by CVP to optimize the circulation were reported in two studies, 14, 29 one of which compared CVP guidance with conventional therapy and oesophageal Doppler ultrasonography. 14 Outcomes were improved by CVP-guided fluid therapy, but greater improvement was seen in patients who underwent oesophageal Doppler ultrasonography. 14 When the invasive nature of measuring CVP and its association with numerous complications were taken into account, 30 -32 the measurement of CVP for haemodynamic monitoring was not considered in the development of the present algorithm.
There is an inverse relationship between FTc and peripheral vascular resistance and this reflects cardiac afterload rather than preload. 33 Following administration of anaesthesia and/or epidural analgesia, the optimal value of FTc as a goal for fluid administration is subject to wide variation and can be difficult to define. 33 Physiologically, circulatory flow may improve even without a decrease in peripheral vascular resistance. In patients with volume depletion due to insufficient fluid therapy, however, increased peripheral vascular resistance can be a good indicator of A Feldheiser, P Conroy, T Bonomo et al. In order to equilibrate fluid homeostasis, the present algorithm includes a crystalloid infusion at a slow baseline rate, to avoid excessive fluid volume that could adversely affect outcome. The need for this was derived from the results of a number of clinical trials that found an association between restrictive fluid regimens and an increase in adverse events. 12, 35, 36 By defining a slow infusion rate, the algorithm avoids situations in which infusions are subject to uncontrolled flushing, or the baseline infusion is too fast for drug administration or fluid boluses outside of the study protocol.
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Arterial hypotension
An association between mortality after cardiac surgery and low mean arterial pressure during the procedure was first described by Reich et al. 37 A study in noncardiac surgery showed that, for every 5min period during which intraoperative systolic arterial pressure was < 80 mmHg, there was an increase in the 1-year mortality rate. 38 It has also been demonstrated that the greater and more sustained the reduction in arterial blood pressure, the greater the adverse impact on 1-year mortality in noncardiac surgery. 39 While acknowledging the findings of these studies, to our knowledge, there are no reports of a reduction in morbidity and mortality in elective surgery by the use of vasopressors.
Cardiac index
Some parameters identified to guide fluid and volume therapy have no fixed cut-off threshold for treatment, but focus on relative changes in haemodynamic variables in response to an intervention (e.g. a > 10% increase in stroke volume from the previous measurement following a fluid bolus). If this strategy were to be used as the sole means of managing fluid administration it might fail to detect a continuous decline in myocardial function, leading to a low cardiac output state that could not be further improved by volume administration. Indeed, enzyme assays and Holter monitoring reveal that myocardial damage is frequently observed in noncardiac surgery. 40 Anaesthetists initiate inotropic therapy for these intraoperative low output states with a high degree of variability, both within routine clinical practice and in the context of clinical studies. To our knowledge, no studies have demonstrated further improvements in postoperative outcomes in noncardiac surgery following the use of positive inotropic therapy after intraoperative volume optimization. For the purposes of the present algorithm, a threshold was chosen at which to commence intraoperative inotropic therapy, based on evidence from guidelines for intensive care in cardiac surgery patients 28 and the treatment of heart failure. 41 The algorithm indicates inotropic therapy following volume optimization titrated to a cardiac index ≥ 2.5 l/min per m 2 . Within the algorithm, each patient receives a fluid bolus in addition to the baseline infusion to optimize preload. While inotropes may acutely improve the haemodynamic and clinical status of patients with low cardiac output syndrome, they may simultaneously promote pathophysiological mechanisms that cause further myocardial injury. 41 As such, the administration of inotropes to reach supranormal levels of oxygen delivery is not included in the haemodynamic algorithm. The goal of inotropic administration is to avoid the low cardiac output state only. Adaptation to supranormal target values for cardiac index can be considered for patients with high perioperative risk. 9
Feasibility study PATIENTS AND METHODS
Study population
The algorithm was introduced into routine perioperative management in October 2008 anaesthesia residents working at the hospital, 15 (11.5%) in years 1 -3 of a 5-year residency programme were trained in the use of the algorithm, and the algorithm was implemented only if one of these trained residents was assigned to the case. The control group consisted of cases classified as ASA ≤ II or where application of the goaldirected algorithm was not feasible. These patients received conventional haemodynamic care.
The study was approved by the Ethics Committee of Charité -Universitätsmedizin Berlin (approval No. EA1/085/11).
Outcomes
Postoperative outcomes included length of hospital stay, need for postoperative ventilator therapy and insurance-reimbursed hospital costs. Outcomes were extracted from a hospital data set, provided by the hospital to healthcare insurance agencies for the description of accumulated costs.
Statistical analyses
Numerical calculations were performed using the R Project for Statistical Computing, version 2.12.1. Descriptive statistics were used to describe patient characteristics. Differences between the two groups were analysed by the Fisher's exact test for categorical variables and by the Mann-Whitney-Wilcoxon test (exact or Monte Carlo approximation, as appropriate) for continuous variables. A P-value < 0.05 was considered to be statistically significant.
RESULTS
A total of 774 surgery cases from the selected hospitals were identified by central hospital administration. Of these, 62 (8.0%) were suitable to be treated according to the goaldirected haemodynamic algorithm. Following implementation of the algorithm, 51 (82.3%) of these patients received continuous infusion of a vasopressor at any point during the operation, and 10 (16.1%) received continuous administration of an inotropic drug.
There were no significant between-group differences in the demographic and clinical characteristics of the patients (Table 3) . Implementation of the algorithm resulted in statistically significant reductions in length of hospital stay (mean ± SD 25.9 ± 25.8 versus 17.7 ± 9.2 days, P = 0.027; Table  4 ) and the need for postoperative ventilator therapy (18.3% versus 4.8%, P = 0.004; Table 4 ), as well as a significant decrease in the number of prolonged hospital stays (relative to the mean length of stay for all hospital patients undergoing the same treatment) (13.1% versus 3.2%, P = 0.023; Table 4 ).
DISCUSSION
The present study demonstrated that implementation (over a 3-year period) of an outcome based, goal-directed, haemodynamic algorithm to guide intraoperative a The algorithm was also tested at the University Hospital Maastricht, Maastricht, The Netherlands and at the Hospital Clinic "Lozano Blesa", Zaragosa, Spain; no patient data from these two institutes were included in the present analysis.
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ERAS feasibility study fluid volume and catecholamine therapy was feasible in daily clinical use and could be performed in various noncardiac surgical procedures by anaesthetists at hospitals in Berlin (Germany), Maastricht (The Netherlands) and Zaragoza (Spain). Other published haemo dynamic algorithms for oesophageal Doppler ultrasonography or pulse contour methods have not included statements regarding feasibility of the protocol or protocol adherence. 6 -8 Only 15 (11.5%) of the anaesthesia residents were trained in the use of the haemodynamic algorithm in the present study and only 62 (8.0%) eligible surgical cases were treated with the algorithm. This indicates good feasibility, since the algorithm could be implemented only if a trained resident was assigned to the case and written informed consent for the use of oesophageal Doppler had been obtained.
The current retrospective analysis of postoperative outcomes showed that, compared with conventional fluid therapy, following the algorithm resulted in reductions in length of hospital stay requirement for ventilator therapy and hospital costs (due to shortened duration of hospital stay). In both patient groups, hospital stay was relatively long compared with enhanced recovery after surgery protocols such as those published for colorectal surgery. 43, 44 It should be noted, however, that there are no defined enhanced recovery protocols for the included surgical procedures, with the exception of hemicolectomy.
In the present study, the goal-directed haemodynamic algorithm was used to guide volume and catecholamine therapy in noncardiac surgery. This algorithm has not been assessed in cardiac surgery, since the appropriate indications for haemodynamic therapy and monitoring in these procedures are outlined in the German S3 guidelines. 28 Despite the broad feasibility of the 
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algorithm observed in elective surgery, its use must be carefully evaluated in haemodynamic instability due to acute haemorrhage or during massive transfusion. We observed that following the algorithm may not meet patient needs rapidly enough in cases of acute haemorrhage. In patients requiring massive transfusions due to surgical trauma or the development of systemic inflammatory response syndrome, following the algorithm could result in excessive transfusions: volume administration leads to an initial increase in stroke volume followed by a rapid decline. Individualized clinical decisions (tailored to the particular patient and their circumstances) must be made in both of these situations, since it has not been possible to validate the feasibility of applying the algorithm in this specific context. It should also be noted that individualized management should be considered in patients at substantially increased risk of perioperative mortality, who are appropriate candidates to receive inotropes titrated to attain supranormal cardiac index values. 9 A substantial proportion of patients show a significant drop in arterial pressure after induction of anaesthesia. 45 These • Received for publication 20 February 2012 • Accepted subject to revision 25 February 2012
• Revised accepted 9 July 2012 Copyright © 2012 Field House Publishing LLP hypotensive periods are commonly treated using drugs that have vasopressor and inotropic effects, such as ephedrine. Administration of these drugs confounds interpretation of the volume administration protocol, since it is not possible to determine whether the resultant changes in stroke volume are due to preload optimization or the inotropic effects of the drugs. For this reason, it is recommended that continuous infusion of a vasopressor (e.g. noradrenaline) be used along with volume administration according to the haemodynamic management algorithm.
The present study demonstrated that use of an outcome-based, goal-directed haemodynamic algorithm to guide intraoperative fluid volume and catecholamine therapy was feasible in different types of noncardiac surgery. Implementation of the algorithm in routine surgical care improved postoperative outcomes, including length of hospital stay, further supporting its clinical relevance.
